Nectar Lifescience Ltd Share Price (NECLIFE)
as on
| Source : NSE
Nectar Lifescience Ltd Stock Performance
as on August 21, 2025 at 4:01 PM IST
Day's Low
Day's High
₹15.17₹15.7
0.85%
Downside
2.61%
Upside
52 Week's Low
52 Week's High
₹13.05₹56.514.71%
Downside
269.28%
Upside
| Market Stats | |
| Previous Close | ₹15.08 |
| Open | ₹15.39 |
| Volume | 1.81L |
| Upper Circuit | ₹15.83 |
| Lower Circuit | ₹14.32 |
| Day's Low | ₹15.17 |
| Day's High | ₹15.7 |
| 52 Week Low | ₹13.05 |
| 52 Week High | ₹56.5 |
| Returns % | |
| 1 Month Return | -17.42 % |
| 3 Month Return | -38.07 % |
| 1 Year Return | -59.65 % |
| 3 Year Return | -34.15 % |
| 5 Year Return | -32.98 % |
Nectar Lifescience Ltd Stock Fundamentals & Key Indicators
Check Nectar Lifescience Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹338.19 Cr
Return on Equity (ROE)
0.47
PE Ratio (TTM)
-1.88
Return on capital employed (ROCE)
5.96
Industry PE ratio
43.54
Beta (LTM)
0.72
P/B Ratio
0.63
Dividend Yield
0PEG Ratio
0.23
Quarterly Earnings Growth YOY
-2228.96
EPS (TTM)
0.22
Sector
Pharmaceuticals
Book Value
47.68
Technical Analysis
Bearish
View Technical Analysis
Nectar Lifescience Ltd Stock's Interest Amongst Investors
Nectar Lifescience Ltd Stock Valuation
Track how Nectar Lifescience Ltd P/E has moved over time to understand its valuation trends.
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Today (-1.88x)
August 20, 2025
Industry (43.54x)
August 20, 2025
Highest (403.33x)
August 26, 2020
Today’s Price to Earnings Ratio: -1.88x
Nectar Lifescience Ltd Financial Results
Get the annual and quarterly financial summary of Nectar Lifescience Ltd, including revenue, profit, loss and more.
Nectar Lifescience Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Nectar Lifescience Ltd.
Nectar Lifescience Ltd Earnings Results
Nectar Lifescience Ltd’s net profit fell -2228.96% since last year same period to ₹-63.23Cr in the Q1 2025-2026. On a quarterly growth basis, Nectar Lifescience Ltd has generated 51.4% jump in its net profits since last 3-months.
Read More about Earnings ResultsNectar Lifescience Ltd Dividends July,2020
In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 per share on 29 Jul 2020 - translating a dividend yield of 0.33%.
Read More about Dividends
Nectar Lifescience Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Nectar Lifescience Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.53% | 0.00 | |
| Foreign Institutions | 0.81% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 54.44% | 1.49 | |
| Others | 0.21% | 19.00 |
Nectar Lifescience Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Nectar Lifescience Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 338.19 | -6.6% | 0.69 | 5 | 1,684 | |
| NA | 49.10 | 39.01% | 0.69 | 1 | 44 | |
| NA | 121.82 | 60.16% | 0.00 | 14 | 95 | |
| NA | 62.65 | 22.94% | 0.00 | 5 | 156 | |
| NA | 88.77 | 0.35% | 0.00 | 1 | 27 |
Nectar Lifescience Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Nectar Lifescience Ltd.
Nectar Lifesciences Faces 20% Drop After Business Sale - 08 Jul, 2025
Nectar Lifesciences announced the sale of its core API and formulation business to Ceph Lifesciences for ₹1,270 crore, leading to a significant 20% drop in stock price, hitting a 52-week low. The restructuring aims to streamline operations and strengthen financials, but investor sentiment turned negative following the announcement.
Insights on Nectar Lifescience Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 53.65% to 54.44% in Jun 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -130.09 Cr → -63.23 Cr (in ₹), with an average increase of 105.7% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 140.0% return, outperforming this stock by 174.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.53% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 22.5% return, outperforming this stock by 82.2%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 1.65% to 0.81% in Jun 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 455.56 Cr → 281.02 Cr (in ₹), with an average decrease of 20.1% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, NECLIFE stock has moved down by -17.4%
About Nectar Lifescience Ltd
Revenue: ₹280.67Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-63.23Cr as on June 2025 (Q1 FY26)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
| Organisation | Nectar Lifescience Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| CEO | Sanjiv Goyal |
| E-voting on shares | Click here to vote |
FAQs
What is Nectar Lifescience Ltd share price today?
Nectar Lifescience Ltd share price today stands at ₹15.3, Open: ₹15.39, Previous Close: ₹15.08, High: ₹15.7, Low: ₹15.17, 52 Week High: ₹56.5, 52 Week Low: ₹13.05 as on .
How to buy Nectar Lifescience Ltd shares ?
To buy Nectar Lifescience Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for NECLIFE or Nectar Lifescience Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Nectar Lifescience Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Nectar Lifescience Ltd?
Today's traded volume of Nectar Lifescience Ltd is 1.81L. Which means that 1.81L shares of Nectar Lifescience Ltd were bought and sold on the stock market during today's trading session.
What is Nectar Lifescience Ltd's market cap today?
Today's market capitalisation of Nectar Lifescience Ltd is ₹338.19 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Nectar Lifescience Ltd?
Nectar Lifescience Ltd’s 52 week high is ₹56.5 and 52 week low is ₹13.05. The current share price of Nectar Lifescience Ltd is ₹15.3, which is -72.92% down from its 52 week high and 17.24% up from its 52 week low.